Your browser doesn't support javascript.
loading
Tumor Microenvironment-Responsive One-for-All Molecular-Engineered Nanoplatform Enables NIR-II Fluorescence Imaging-Guided Combinational Cancer Therapy.
Wu, Gui-Long; Liu, Fen; Li, Na; Wang, Feirong; Yang, Sha; Wu, Fan; Xiao, Hao; Wang, Minghui; Deng, Sanling; Kuang, Xin; Fu, Qian; Wu, Peixian; Kang, Qiang; Sun, Lijuan; Li, Zelong; Lin, Nanyun; Wu, Yinyin; Tan, Senyou; Chen, Guodong; Tan, Xiaofeng; Yang, Qinglai.
Afiliación
  • Wu GL; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Liu F; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Li N; Department of Radiology, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China.
  • Wang F; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Yang S; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Wu F; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Xiao H; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Wang M; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Deng S; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Kuang X; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Fu Q; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Wu P; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Kang Q; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Sun L; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Li Z; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Lin N; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Wu Y; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Tan S; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Chen G; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Tan X; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
  • Yang Q; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital, and Center for Molecular Imaging Probe of Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Anal Chem ; 95(47): 17372-17383, 2023 11 28.
Article en En | MEDLINE | ID: mdl-37963241
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fotoquimioterapia / Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Anal Chem Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fotoquimioterapia / Nanopartículas / Neoplasias Límite: Humans Idioma: En Revista: Anal Chem Año: 2023 Tipo del documento: Article País de afiliación: China